Literature DB >> 11349477

Depression and dysthymia.

J D Moore1, J R Bona.   

Abstract

The advances made in the 1980s and 1990s have yielded many advances in the diagnosis and treatment of depression and dysthymia. Skill of the clinician is important in sorting out the diagnosis, taking care to consider the various medical conditions that can cause depression or disguise themselves as depression. Depressive disorders are highly treatable conditions. Clinicians must overcome the stigma associated with these disorders to alleviate the pain and suffering of those afflicted. The advances in treatment have been enormous and continue to grow. The keys to these treatments lie in continuing to acquire the knowledge to unlock all of the causes of depression. An appendix follows listing medications commonly used in the treatment of depression or for other conditions in patients under treatment for depression.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11349477     DOI: 10.1016/s0025-7125(05)70333-3

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  6 in total

1.  Nicotine Addiction and Psychiatric Disorders.

Authors:  Munir Gunes Kutlu; Vinay Parikh; Thomas J Gould
Journal:  Int Rev Neurobiol       Date:  2015-09-19       Impact factor: 3.230

Review 2.  Economic considerations in the prescribing of third-generation antidepressants.

Authors:  Stuart Montgomery; John J Doyle; Lee Stern; Christopher R McBurney
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

3.  Effect of depression and psychosocial stressors on cessation self-efficacy in mothers who smoke.

Authors:  Melanie K Prusakowski; Frances S Shofer; Karin V Rhodes; Angela M Mills
Journal:  Matern Child Health J       Date:  2011-07

4.  The economic impact of introducing serotonin-noradrenaline reuptake inhibitors into the Brazilian national drug formulary: cost-effectiveness and budget-impact analyses.

Authors:  Márcio Machado; Michael Iskedjian; Inés A Ruiz; Thomas R Einarson
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

5.  Managing Suicide Attempts: Guidelines for the Primary Care Physician.

Authors:  Catherine Goertemiller Carrigan; Denis J. Lynch
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2003-08

6.  Cost-effectiveness evaluation of escitalopram in major depressive disorder in Italy.

Authors:  Claudio Mencacci; Guido Di Sciascio; Pablo Katz; Claudio Ripellino
Journal:  Clinicoecon Outcomes Res       Date:  2013-02-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.